Latest filing published 13 Jun 2025 for Janux Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Alana B. McNulty is a declared insider at 2 companies (senior executive); the most frequent names are Janux Therapeutics, Inc. and eFFECTOR Therapeutics, Inc. In total, 3 filings cover trades dated from 25 August 2021 to 11 June 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 13 June 2025, reports a share grant in Janux Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations